Ned Nwoko Foundation hails WHO-approved malaria vaccine

A health worker prepares a malaria vaccination for a child at Yala Sub-County hospital, in Yala, Kenya, on October 7, 2021. - World Health Organization (WHO) approved using the malaria vaccine, Mosquirix, on children between 5-month to 5-year old in sub-Saharan Africa and other parts with moderate to high malaria transmission after the malaria vaccine implementation programme (MVIP) in Ghana, Kenya, and Malawi since 2019. (Photo by Brian Ongoro / AFP)

The Prince Ned Nwoko Malaria Eradication Project, yesterday, hailed the approval by World Health Organisation (WHO) for wide-use of the RTSS malaria vaccine in countries and the endorsement of the Foundation to coordinate the national response to implement the jab in Nigeria

The Prince Ned Nwoko Foundation, a non-governmental organisation headquartered in Abuja, through its Malaria Eradication Project, in the last six months, sought and received approval from the Federal Ministry of Health to support and coordinate a national response toward malaria control and elimination through strategic partnerships to promote and implement the RTSS malaria vaccine implementation programme (MVIP) in Nigeria.

The Foundation, in a statement, said it believes that as a country with the highest malaria burden globally, a strong local response is urgently required to achieve targets set in the National Malaria Strategic Plan (NMSP, 2021-2025).

Chairman and founder, Prince Ned Nwoko, said a technology-driven solution for effective malaria control and elimination through the use of vaccines, in addition to existing interventions, is critical to attaining set targets for Nigeria in the light of the high malaria mortality and morbidity burden.

“The Prince Ned Nwoko Malaria Eradication Project invites the public and private sector partners to come on board, as efforts are currently on to establish a strong multi-sector partnership to drive this great process that also requires the optimal use of existing interventions, in addition to the vaccines to deploy a comprehensive package for effective malaria control to elimination,” the statement added.

Join Our Channels